Published in Clin Gastroenterol Hepatol on December 07, 2011
New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil (2013) 0.93
Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf) (2014) 0.91
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region. J Neurogastroenterol Motil (2016) 0.83
Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract (2013) 0.80
Acid suppression for reflux disease: "off-the-peg" or a tailored approach? Clin Gastroenterol Hepatol (2011) 0.77
Prospective, Randomized Ex Vivo Trial to Assess the Ideal Stapling Site for Endoscopic Fundoplication with Medigus Ultrasonic Surgical Endostapler. Gastroenterol Res Pract (2016) 0.76
Dexlansoprazole - a new-generation proton pump inhibitor. Prz Gastroenterol (2015) 0.76
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR. Ther Clin Risk Manag (2015) 0.76
25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut Liver (2016) 0.76
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. Therap Adv Gastroenterol (2017) 0.75
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole. Clin Exp Gastroenterol (2016) 0.75
Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease. Dig Dis Sci (2017) 0.75
The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med (2003) 3.32
Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens (2004) 2.88
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med (2007) 1.45
Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data. Am J Gastroenterol (2011) 1.39
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci (2011) 1.35
Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2011) 1.27
Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci (2006) 1.25
The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol (2006) 1.23
Grade 4 events are as important as AIDS events in the era of HAART. J Acquir Immune Defic Syndr (2003) 1.21
Moyamoya disease in China: its clinical features and outcomes. Stroke (2011) 1.16
Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population. J Manag Care Pharm (2006) 1.09
Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Curr Med Res Opin (2011) 1.03
Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J Clin Endocrinol Metab (2008) 0.97
The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol (2011) 0.95
Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study. Stroke (2011) 0.94
D-Alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin. Int J Antimicrob Agents (2008) 0.94
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl (2012) 0.91
Comparisons of screening colonoscopy performed by a nurse practitioner and gastroenterologists: a single-center randomized controlled trial. Gastroenterol Nurs (2011) 0.90
Characterization and inhibitor discovery of one novel malonyl-CoA: acyl carrier protein transacylase (MCAT) from Helicobacter pylori. FEBS Lett (2006) 0.89
A new beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Helicobacter pylori: Molecular cloning, enzymatic characterization, and structural modeling. Biochem Biophys Res Commun (2005) 0.88
Structures of protein-protein complexes involved in electron transfer. Nature (2013) 0.88
Proton-coupled electron transfer in the catalytic cycle of Alcaligenes xylosoxidans copper-dependent nitrite reductase. Biochemistry (2011) 0.87
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 0.84
Methylation levels at IGF2 and GNAS DMRs in infants born to preeclamptic pregnancies. BMC Genomics (2013) 0.84
Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China. Cerebrovasc Dis (2012) 0.84
Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population. Cerebrovasc Dis (2010) 0.82
Natural product juglone targets three key enzymes from Helicobacter pylori: inhibition assay with crystal structure characterization. Acta Pharmacol Sin (2008) 0.82
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci (2007) 0.81
Taste comparisons for lansoprazole strawberry-flavoured delayed-release orally disintegrating tablet and ranitidine peppermint-flavoured syrup in children. Clin Drug Investig (2005) 0.81
Enzymatic characterization and inhibitor discovery of a new cystathionine {gamma}-synthase from Helicobacter pylori. J Biochem (2007) 0.81
Colorectal cancer screening compliance and contemplation in gynecology patients. J Womens Health (Larchmt) (2010) 0.81
Importance of determining indication for colonoscopy: implications for practice and policy original. Clin Gastroenterol Hepatol (2014) 0.80
Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis (2015) 0.79
Editorial: Interval cancers after colonoscopy: the importance of training. Am J Gastroenterol (2010) 0.79
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants. Qual Life Res (2010) 0.79
Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence. J Am Pharm Assoc (2003) (2014) 0.78
Validation of a new physical activity questionnaire for a sedentary population. Dig Dis Sci (2011) 0.78
Reduced effectiveness of standard recruitment for deceased organ donor registration: the need for population-specific recruitment materials. Dig Dis Sci (2011) 0.78
Seasonal patterns of abdominal pain consultations among adults and children. J Pediatr Gastroenterol Nutr (2013) 0.77
Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis. J Community Health (2002) 0.77
Stabilization of Phenylalanine Ammonia Lyase from Rhodotorula glutinis by Encapsulation in Polyethyleneimine-Mediated Biomimetic Silica. Appl Biochem Biotechnol (2015) 0.77
In vivo evaluation of an in-situ hydrogel system for vaginal administration. Pharmazie (2014) 0.77
Epitope mapping of monoclonal antibody 1B9 against plasmodium falciparum-derived macrophage migration inhibitory factor. Immunol Invest (2009) 0.77
Preparation of highly substituted gamma-lactam follicle stimulating hormone receptor agonists. Bioorg Med Chem (2005) 0.76
Late presentation of colorectal cancer in a vulnerable population. Am J Gastroenterol (2013) 0.76
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa. Clin J Am Soc Nephrol (2012) 0.75
Transplant tourism to China: the impact on domestic patient-care decisions. Clin Transplant (2009) 0.75
Race/Ethnicity and Primary Language: Health Beliefs about Colorectal Cancer Screening in a Diverse, Low-Income Population. J Health Care Poor Underserved (2015) 0.75
Confounding factors affecting association of antihypertensive medications and pulse pressure. Am J Med (2004) 0.75
Serum preadipocyte factor-1 is increased in fetuses of pregnancy complicated with severe preeclampsia. Clin Chim Acta (2013) 0.75
Changes in Hemodynamic Response Patterns in Motor Cortices Measured by Task-Based Functional Magnetic Resonance Imaging in Patients With Moyamoya Disease. J Comput Assist Tomogr (2016) 0.75
Morphometric Study of Endoscopic Transoccipital Approach to Lateral Ventricle With Magnetic Resonance Imaging. J Craniofac Surg (2016) 0.75
Characterization of peptide deformylase homologues from Staphylococcus epidermidis. Microbiology (2010) 0.75
Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer. Expert Opin Pharmacother (2007) 0.75
How to value technological innovation: a proposal for determining relative clinical value. Gastroenterology (2012) 0.75
"Spontaneous" passage of a pancreatic duct stone. Gastrointest Endosc (2003) 0.75
[NPM1 and CEBPA mutations in pediatric cytogenetically normal acute myeloid leukemia]. Zhonghua Er Ke Za Zhi (2014) 0.75
[A multicenter study on the revalidation of validated conversion factor for the conversion of BCRABL（P210）transcript levels to the international scale in chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi (2015) 0.75